Obesity drugs are not magic: a critical and necessary look at GLP-1 receptor agonists
Obesity has become one of the main threats to public health worldwide. Its prevalence continues to increase in both industrialised countries and low- and middle-income countries, with alarming figures among adults. This clinical reality is not trivial: obesity is associated with an increased risk of type 2 diabetes, cardiovascular disease, certain types of cancer, cognitive…